Home - VHIO

The 4th annual patient day focuses on gastric cancer research

As part of the Severo Ochoa Patient and Citizen Involvement Programme, the 4th Patient Day was held on 10 April,...

Rodrigo Toledo y Carlota Arenillas - VHIO

Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region

Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in...

Integrating AI into real-world radiology data to advance cancer diagnosis and personalized care in oncology: advantages and challenges

Led by investigators of VHIO’s Radiomics Group, a review article published in ESMO Real-World Data and Digital Oncology—the European Society...

As part of the Severo Ochoa Patient and Citizen Involvement Programme, the 4th Patient Day was held on 10 April,...

The 4th annual patient day focuses on gastric cancer research

Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in...

Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region

Led by investigators of VHIO’s Radiomics Group, a review article published in ESMO Real-World Data and Digital Oncology—the European Society...

Integrating AI into real-world radiology data to advance cancer diagnosis and personalized care in oncology: advantages and challenges

Latest News

As part of the Severo Ochoa Patient and Citizen Involvement Programme, the 4th Patient Day was held on 10 April,...

14 April 2025

The 4th annual patient day focuses on gastric cancer research

As part of the Severo Ochoa Patient and Citizen Involvement Programme, the 4th Patient Day was held on 10 April,...

Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in...

09 April 2025

Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region

Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in...

Led by investigators of VHIO’s Radiomics Group, a review article published in ESMO Real-World Data and Digital Oncology—the European Society...

04 April 2025

Integrating AI into real-world radiology data to advance cancer diagnosis and personalized care in oncology: advantages and challenges

Led by investigators of VHIO’s Radiomics Group, a review article published in ESMO Real-World Data and Digital Oncology—the European Society...

The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and...

26 March 2025

Vall d’Hebron shows long-term safety of CAR-T therapy in aggressive lymphoma patients

The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and...

VIEW MORE NEWS

PRINCIPAL RESEARCHERS

Cristina Saura

Breast Cancer & Melanoma Group

The main area of expertise of the Breast Cancer Group is clinical research focused on drug development and associated translational…

Elena Garralda

Early Clinical Drug Development Group

We focus on proof-of-concept and proof-of-mechanism trials with targeted therapies, with particular emphasis on cell signaling, cancer stem cells, and…

Teresa Macarulla

Gastrointestinal and Endocrine Tumors Group

Our group continues to play an essential role in developing molecular therapies against GI malignancies. We make important contributions to…

Alena Gros

Tumor Immunology and Immunotherapy Group

Our group focuses on better understanding the naturally occurring T-cell response to cancer and establishing ways to exploit these antitumor…

Events

Thursday 13 November 25 - 09:00 AM 2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology

VIEW DETAIL